← All trials
NCT02203812
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2015
- Primary completion
- Feb 1, 2016
- Completion date
- May 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 32
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- CD Pharma India Pvt. Ltd.Lead sponsor
- Government Dental College and Hospital, Vijayawada, Andhra PradeshOverall official - principal investigator
- Government Dental College and Hospital, Vijayawada, Andhra PradeshStudy director
- Government Dental College and Hospital, Vijayawada, Andhra PradeshCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.